News Background

Oxford, UK – 21 June 2016. OGT, The Molecular Genetics Company, has further expanded its extensive catalogue of fluorescence in situ hybridisation (FISH) products with 9 new CytoCell® probes. The range now includes ETV6 Proximal Probe Green, ETV6 Distal Probe Red, MPO Probe Red, TP53 Probe Green, NUP214 Probe Red, DEK Probe Green, TAS2R1 (5p15.31) Probe Green, Chromosome 9 Satellite III Probe Aqua and Chromosome 15 Alpha Satellite Probe Red. These cost-effective and quality-assured probes produce specific, high-intensity signals with excellent contrast and minimal background for the utmost confidence in results. Optimised for use on common sample types, the probes are also pre-mixed in hybridisation buffer, increasing ease of use and reducing errors in the laboratory.

Highlighting OGT’s renowned customer service, the new additions to the range have been developed in response to high customer demand via the CytoCell myProbes® FISH probes service. This custom probe design and manufacturing service enables OGT customers to purchase unique, fully quality-assured FISH probes for virtually any sequence in the entire human genome using the proprietary CytoCell BAC clone collection.

Faidra Partheniou, Haematology product manager at OGT explained, ‘These new probes are a real testament to the way OGT listens and responds to customer needs. We had a lot of people requesting these genes via our myProbes service so we wanted to make them readily available. Our dedicated customer support also ensures that we’re consistently there for our customers with expert advice and evaluation support. OGT offers the largest portfolio of FISH probes available and we look forward to announcing further new probes in the near future.’

The new additions to the CytoCell probe range are currently only available within North America as analyte specific reagents (ASRs), analytical and performance characteristics are not established. CE-marked IVD versions for sale in Europe are anticipated.

About OGT

OGT, a Sysmex Group company, is a leading global provider of clinical and diagnostic genomic solutions that are created for scientists by scientists - including CytoCell®, CytoSure® and SureSeq™ ranges of FISH, microarray and NGS products. The company is dedicated to creating products that enable researchers and clinical decision makers to reach the right care decisions for each patient, every time. OGT strives to unlock the future of genetic clinical care with a commitment to working in partnership with its customers - not only by sharing its expertise of 25 years at the forefront of genetic endeavour, but also by working closely with scientists to understand their unique challenges, and to customise its approach to meet their exact needs. Dedicated to improving clinical care, OGT believes that through partnership—together—we’ll achieve more.

 

For more information on the Company, please visit our website at ogt.com

 

CytoSure®, SureSeq™ and myProbes®: For Research Use Only, not for use in diagnostic procedures. CytoCell: Some products may not be available in your region.

 

About Sysmex Corporation

Sysmex Corporation is a world leader in clinical laboratory systemization and solutions, including laboratory diagnostics, laboratory automation and clinical information systems. Serving customers for more than 50 years, Sysmex focuses on technological leadership in diagnostic science and information tools that make a difference in the health of people worldwide. The company is also exploring emerging opportunities in the life science field. Its R&D efforts focus on the development of high-value-added testing and diagnostic technologies that are innovative, original and optimize individual health. Sysmex also seeks to leverage its state-of-the-art technologies for cell, gene and protein analysis. The company, headquartered in Kobe, Japan, has subsidiaries in North America, Latin America, Europe, the Middle East, Africa, China and Asia Pacific and employs more than 9,000 employees worldwide. Sysmex Corporation is listed in the top tier of the Tokyo Stock Exchange.

 

For more information about Sysmex Corporation and its affiliate companies, please visit www.sysmex.co.jp/en/.

You might also be interested in

OGT's CytoCell portfolio available via Sysmex in China and Spain Listing Image

OGT's CytoCell portfolio available via Sysmex in China and Spain

06 Jul 2020

Addition of direct-sales territories follows successes across Europe and APAC and provides customers with enhanced local sales and support services.

Read
OGT celebrates opening of new Cambridge site Listing Image

OGT celebrates opening of new Cambridge site

06 Jun 2019

State-of-the-art premises increases operational footprint and will host Sysmex global R&D facility.

Read
FDA grants de novo designation for OGT’s AML/MDS FISH probes Listing Image

FDA grants de novo designation for OGT’s AML/MDS FISH probes

30 Jan 2019

Clearance enables accurate and easy-to-interpret AML and MDS detection with reduced validation burden.

Read
All News
CTA Icon

Stay up-to-date with the latest news from OGT, including new products, support resources, and our DNA Dispatch newsletter